doi: 10.1016/j.cmet.2016.04.022 48 UeharaKSostre-ColonJGavinMSantoleriDLeonardKAJacobsRLet al
GLP-1 receptor agonists are licensed in the UK for type 2 diabetes and weight management under specific NICE criteria, not for cortisol regulation
Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen+ IV and NAD+ IV in healthy adults
Unlike earlier agents such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP and GLP-1 receptor agonist), retatrutide simultaneously activates three distinct hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
They wanted the weight and metabolic benefits, yet a subset told us they were struggling with new or worsened anxiety, low mood, or fogginess that made work and relationships harder